26.11.2012 • News

Prof. Stefan Buchholz to head Evonik's R&D group Creavis

Prof. Stefan Buchholz (50) has assumed the position as head of Creavis, the strategic R&D unit of Evonik. Buchholz studied chemistry in Marburg, Germany and received his doctorate from the Max-Planck Institute of Polymer Research in Mainz. He finished his Post-doc at the Harvard University in Boston, USA. In 2011 Buchholz was appointed honorary professor by the University of Stuttgart. Prof. Buchholz began his professional career within Evonik in 1993 as scientific assistant in the business unit Industry and Fine Chemicals of the former Degussa in Frankfurt. From 1998 to 2000 he worked as plant assistant at the Antwerp, Belgium site before he took over management of the Biotechnology Project House at the Hanau site. From 2008 until recently, Prof. Buchholz was Head of Innovation Management in the business unit Advanced Intermediates.

Company

Logo:

Evonik Industries AG

Rellinghauser Straße 1-11
45128 Essen
Germany

Company contact







Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

most read